CN101143202A - 一种对化学性肝损伤具有保护作用的复方口服制剂 - Google Patents
一种对化学性肝损伤具有保护作用的复方口服制剂 Download PDFInfo
- Publication number
- CN101143202A CN101143202A CNA2006100310111A CN200610031011A CN101143202A CN 101143202 A CN101143202 A CN 101143202A CN A2006100310111 A CNA2006100310111 A CN A2006100310111A CN 200610031011 A CN200610031011 A CN 200610031011A CN 101143202 A CN101143202 A CN 101143202A
- Authority
- CN
- China
- Prior art keywords
- preparation
- compound oral
- oral administration
- liver injury
- administration preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 42
- 231100000753 hepatic injury Toxicity 0.000 title claims abstract description 23
- 150000001875 compounds Chemical class 0.000 title claims abstract description 21
- 239000000126 substance Substances 0.000 title claims abstract description 19
- 206010067125 Liver injury Diseases 0.000 title claims description 17
- 230000009993 protective function Effects 0.000 title 1
- 230000001681 protective effect Effects 0.000 claims abstract description 11
- 239000003814 drug Substances 0.000 claims description 20
- 239000000843 powder Substances 0.000 claims description 17
- 229940079593 drug Drugs 0.000 claims description 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 10
- 239000008187 granular material Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 6
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 210000000582 semen Anatomy 0.000 claims description 6
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 claims description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 5
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims description 5
- 229930003268 Vitamin C Natural products 0.000 claims description 5
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 claims description 5
- 229930003944 flavone Natural products 0.000 claims description 5
- 150000002212 flavone derivatives Chemical class 0.000 claims description 5
- 235000011949 flavones Nutrition 0.000 claims description 5
- 230000008595 infiltration Effects 0.000 claims description 5
- 238000001764 infiltration Methods 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 claims description 5
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 claims description 5
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 claims description 5
- 235000005493 rutin Nutrition 0.000 claims description 5
- 229960004555 rutoside Drugs 0.000 claims description 5
- 235000019154 vitamin C Nutrition 0.000 claims description 5
- 239000011718 vitamin C Substances 0.000 claims description 5
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 4
- 239000000796 flavoring agent Substances 0.000 claims description 4
- 235000019634 flavors Nutrition 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- 235000013878 L-cysteine Nutrition 0.000 claims description 3
- 239000004201 L-cysteine Substances 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 241001465754 Metazoa Species 0.000 abstract description 8
- 238000012360 testing method Methods 0.000 abstract description 7
- 230000036541 health Effects 0.000 abstract description 5
- 210000002966 serum Anatomy 0.000 abstract description 5
- 108010003415 Aspartate Aminotransferases Proteins 0.000 abstract description 4
- 102000004625 Aspartate Aminotransferases Human genes 0.000 abstract description 4
- 238000005516 engineering process Methods 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 4
- 230000001575 pathological effect Effects 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 3
- 231100000283 hepatitis Toxicity 0.000 abstract description 2
- 208000006454 hepatitis Diseases 0.000 abstract description 2
- WTPPRJKFRFIQKT-UHFFFAOYSA-N 1,6-dimethyl-8,9-dihydronaphtho[1,2-g][1]benzofuran-10,11-dione;1-methyl-6-methylidene-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(=C)C3=CC=C2C2=C1C(C)=CO2.O=C1C(=O)C2=C3CCC=C(C)C3=CC=C2C2=C1C(C)=CO2 WTPPRJKFRFIQKT-UHFFFAOYSA-N 0.000 abstract 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 abstract 1
- 108010082126 Alanine transaminase Proteins 0.000 abstract 1
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241000202726 Bupleurum Species 0.000 abstract 1
- 244000146462 Centella asiatica Species 0.000 abstract 1
- 235000004032 Centella asiatica Nutrition 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 244000010000 Hovenia dulcis Species 0.000 abstract 1
- 235000008584 Hovenia dulcis Nutrition 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 244000042430 Rhodiola rosea Species 0.000 abstract 1
- 235000003713 Rhodiola rosea Nutrition 0.000 abstract 1
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 235000006886 Zingiber officinale Nutrition 0.000 abstract 1
- 235000008397 ginger Nutrition 0.000 abstract 1
- 244000132619 red sage Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 238000001694 spray drying Methods 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 238000010171 animal model Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 3
- 230000007850 degeneration Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 239000003595 mist Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- -1 L-cysteine, vitamin Chemical class 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 231100000025 genetic toxicology Toxicity 0.000 description 2
- 230000001738 genotoxic effect Effects 0.000 description 2
- 231100000234 hepatic damage Toxicity 0.000 description 2
- 230000008818 liver damage Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 230000007863 steatosis Effects 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 208000005584 Alcoholic Intoxication Diseases 0.000 description 1
- 208000031404 Chromosome Aberrations Diseases 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 206010019668 Hepatic fibrosis Diseases 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 208000031320 Teratogenesis Diseases 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 231100000481 chemical toxicant Toxicity 0.000 description 1
- 231100000005 chromosome aberration Toxicity 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000010224 hepatic metabolism Effects 0.000 description 1
- 206010019692 hepatic necrosis Diseases 0.000 description 1
- 230000007866 hepatic necrosis Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 231100000334 hepatotoxic Toxicity 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 210000003240 portal vein Anatomy 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 动物数(只) | GPT(IU/L) | GOT(IU/L) | A/G |
正常对照CCL4模型低剂量中剂量高剂量 | 1010101010 | 36±7*584±221446±64362±44*182±28* | 80±7*677±66625±32554±30*183±16* | 1.55±0.211.83±0.281.83±0.501.79±0.501.92±0.44 |
组别 | 动物数 | 颗粒变性 | 水样变性 | 气球变性 | 脂肪变性 | 胞浆凝聚 | 细胞坏死 | 炎症细胞浸润 | 总分 | 平均分 |
正常对照CCL4模型低剂量中剂量高剂量 | 1010101010 | 1414141211 | 06993 | 04630 | 18843 | 227191612 | 027181512 | 0991210 | 1791837151 | 1.7±0.7*9.1±2.88.3±3.47.1±3.55.1±1.8* |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006100310111A CN101143202B (zh) | 2006-09-11 | 2006-09-11 | 一种对化学性肝损伤具有保护作用的复方口服制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006100310111A CN101143202B (zh) | 2006-09-11 | 2006-09-11 | 一种对化学性肝损伤具有保护作用的复方口服制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101143202A true CN101143202A (zh) | 2008-03-19 |
CN101143202B CN101143202B (zh) | 2010-12-08 |
Family
ID=39206056
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006100310111A Active CN101143202B (zh) | 2006-09-11 | 2006-09-11 | 一种对化学性肝损伤具有保护作用的复方口服制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101143202B (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101550425B (zh) * | 2008-03-31 | 2011-03-30 | 北京大学 | 一种可调控的肝损伤动物模型的制作方法及其专用载体 |
CN101987192B (zh) * | 2009-07-29 | 2012-01-25 | 桂林金可保健品有限公司 | 一种保肝护肝的中药组合物及其制备方法和质量控制方法 |
CN102784366A (zh) * | 2012-09-03 | 2012-11-21 | 赵全成 | 一种具有醒酒保肝作用的药物组合物 |
CN104489698A (zh) * | 2014-12-02 | 2015-04-08 | 汤臣倍健股份有限公司 | 一种组合物、用途及保健品 |
CN108244632A (zh) * | 2018-02-08 | 2018-07-06 | 上海高博特生物保健品有限公司 | 一种多功能固态保健食品及其制备方法 |
CN108339051A (zh) * | 2018-05-03 | 2018-07-31 | 云南彝山天宝生物医药有限公司 | 一种治疗化学性肝损伤的药物、制备方法及其应用 |
CN109758570A (zh) * | 2019-03-27 | 2019-05-17 | 汤臣倍健股份有限公司 | 一种对酒精性肝损伤具有辅助保护作用的组合物及其保健品、应用 |
-
2006
- 2006-09-11 CN CN2006100310111A patent/CN101143202B/zh active Active
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101550425B (zh) * | 2008-03-31 | 2011-03-30 | 北京大学 | 一种可调控的肝损伤动物模型的制作方法及其专用载体 |
CN101987192B (zh) * | 2009-07-29 | 2012-01-25 | 桂林金可保健品有限公司 | 一种保肝护肝的中药组合物及其制备方法和质量控制方法 |
CN102784366A (zh) * | 2012-09-03 | 2012-11-21 | 赵全成 | 一种具有醒酒保肝作用的药物组合物 |
CN102784366B (zh) * | 2012-09-03 | 2013-07-31 | 赵全成 | 一种具有醒酒保肝作用的药物组合物 |
CN104489698A (zh) * | 2014-12-02 | 2015-04-08 | 汤臣倍健股份有限公司 | 一种组合物、用途及保健品 |
CN108244632A (zh) * | 2018-02-08 | 2018-07-06 | 上海高博特生物保健品有限公司 | 一种多功能固态保健食品及其制备方法 |
CN108339051A (zh) * | 2018-05-03 | 2018-07-31 | 云南彝山天宝生物医药有限公司 | 一种治疗化学性肝损伤的药物、制备方法及其应用 |
CN109758570A (zh) * | 2019-03-27 | 2019-05-17 | 汤臣倍健股份有限公司 | 一种对酒精性肝损伤具有辅助保护作用的组合物及其保健品、应用 |
Also Published As
Publication number | Publication date |
---|---|
CN101143202B (zh) | 2010-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105395577B (zh) | 一种降尿酸组合物及其制剂 | |
CN101143202B (zh) | 一种对化学性肝损伤具有保护作用的复方口服制剂 | |
CN102670763A (zh) | 一种对化学性肝损伤具有辅助保护作用的组合物及其制备方法 | |
CN109674958A (zh) | 一种具有降尿酸功效的中药组合物及其制备方法和应用 | |
CN102370687B (zh) | 一种治疗结肠炎的中药复方制剂及其制备方法 | |
CN106135891A (zh) | 一种对酒精性肝损伤具有保护功能的保健食品 | |
CN103655919A (zh) | 一种中药保肝制剂 | |
CN101829274B (zh) | 一种治疗肝病的药物 | |
CN101524422B (zh) | 一种具有降血脂功能的保健品、它们的制备方法与用途 | |
CN102068494A (zh) | 对化学性肝损伤有治疗作用的保健胶囊及其制备方法 | |
CN108721431B (zh) | 一种排重金属的中药组合物及其应用 | |
CN107890528B (zh) | 一种治疗高尿酸血症的中药组合物及其制备方法 | |
CN103610795B (zh) | 一种杜仲降压口服制剂的制备方法 | |
CN100579544C (zh) | 一种治疗胆囊炎、胆结石的中药制剂及其制备方法 | |
CN103169825A (zh) | 一种用于治疗畜禽肠道疾病的药物 | |
CN101518642B (zh) | 液体内服剂 | |
CN100464767C (zh) | 用于治疗高尿酸血症的药物组合物 | |
CN101524447A (zh) | 一种治疗便秘的药物组合及其制备工艺 | |
CN101143203A (zh) | 一种具有护肝养胃功能的复方口服液 | |
CN109349640A (zh) | 一种改善化学性肝损伤的保健胶囊 | |
CN102327369B (zh) | 治疗肝损伤的药物组合物、药物及制备方法 | |
CN113144164B (zh) | 一种治疗胃肠型感冒的中药组合物及其制剂 | |
CN103142751A (zh) | 治疗仔猪缺铁性贫血的中药组合物 | |
CN110420264B (zh) | 一种中药组合物及其制备方法和应用 | |
CN109771480B (zh) | 一种治疗畜禽肝中毒的中药组合物及其制备方法和制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Compound oral administration preparation with protective function to chemical liver injury Effective date of registration: 20130301 Granted publication date: 20101208 Pledgee: Bank of China Limited by Share Ltd. Shanghai Putuo branch Pledgor: SHANGHAI HUILUN LIFE SCIENCE & TECHNOLOGY Co.,Ltd. Registration number: 2013310000009 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20150506 Granted publication date: 20101208 Pledgee: Bank of China Limited by Share Ltd. Shanghai Putuo branch Pledgor: SHANGHAI HUILUN LIFE SCIENCE & TECHNOLOGY Co.,Ltd. Registration number: 2013310000009 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Compound oral administration preparation with protective function to chemical liver injury Effective date of registration: 20150512 Granted publication date: 20101208 Pledgee: Bank of China Limited by Share Ltd. Shanghai Putuo branch Pledgor: SHANGHAI HUILUN LIFE SCIENCE & TECHNOLOGY Co.,Ltd. Registration number: 2015310000017 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20180227 Granted publication date: 20101208 Pledgee: Bank of China Limited by Share Ltd. Shanghai Putuo branch Pledgor: SHANGHAI HUILUN LIFE SCIENCE & TECHNOLOGY Co.,Ltd. Registration number: 2015310000017 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190505 Address after: Room 304-12, 665 Zhangjiang Road, Shanghai Free Trade Pilot Area, Pudong New Area, Shanghai 201210 Patentee after: Shanghai Huilun Pharmaceutical Technology Co.,Ltd. Address before: Room 650-10, Building No. 2, 351 Guoshoujing Road, Zhangjiang High-tech Park, Shanghai, 201203 Patentee before: SHANGHAI HUILUN LIFE SCIENCE & TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190814 Address after: Room 650-10, Building No.2, 351 Guoshoujing Road, Shanghai Pudong New Area, 201203 Patentee after: SHANGHAI HUILUN LIFE SCIENCE & TECHNOLOGY Co.,Ltd. Address before: Room 304-12, 665 Zhangjiang Road, Shanghai Free Trade Pilot Area, Pudong New Area, Shanghai 201210 Patentee before: Shanghai Huilun Pharmaceutical Technology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CP01 | Change in the name or title of a patent holder |
Address after: Room 650-10, Building No.2, 351 Guoshoujing Road, Shanghai Pudong New Area, 201203 Patentee after: Shanghai Hui Bio Technology Co.,Ltd. Address before: Room 650-10, Building No.2, 351 Guoshoujing Road, Shanghai Pudong New Area, 201203 Patentee before: SHANGHAI HUILUN LIFE SCIENCE & TECHNOLOGY Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211221 Address after: 201100 floor 10, building 5, No. 525, Yuanjiang Road, Minhang District, Shanghai Patentee after: Shanghai Hui Bio Technology Co.,Ltd. Patentee after: SHANGHAI HUILUN JIANGSU PHARMACEUTICAL Co.,Ltd. Address before: Room 650-10, building 2, 351 GuoShouJing Road, Shanghai pilot Free Trade Zone, Pudong New Area, Shanghai, 201203 Patentee before: Shanghai Hui Bio Technology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CP03 | Change of name, title or address |
Address after: 200241 floor 10, building 5, No. 525, Yuanjiang Road, Minhang District, Shanghai Patentee after: Shanghai Huilun Pharmaceutical Co.,Ltd. Patentee after: SHANGHAI HUILUN JIANGSU PHARMACEUTICAL Co.,Ltd. Address before: 201100 floor 10, building 5, No. 525, Yuanjiang Road, Minhang District, Shanghai Patentee before: Shanghai Hui Bio Technology Co.,Ltd. Patentee before: SHANGHAI HUILUN JIANGSU PHARMACEUTICAL Co.,Ltd. |
|
CP03 | Change of name, title or address |